BIOMAT Database Logo BIOMAT Database Logo

Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity. 2016

Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Univ. Lille, Inserm, CHU Lille , UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, F-59000 Lille, France.

Benzopyridothiadiazepine (2a) and benzopyridooxathiazepine (2b) were modified to produce tricyclic quinazolinone 15-18 or benzothiadiazine 26-27 derivatives. These compounds were evaluated in cytotoxicity and tubulin inhibition assays and led to potent inhibitors of tubulin polymerization. N-[2(4-Methoxyphenyl)ethyl]-1,2-dihydro-pyrimidino[2,1-b]quinazolin-6-one (16a) exhibited the best in vitro cytotoxic activity (GI50 10-66.9 nM) against the NCI 60 human tumor cell line and significant potency against tubulin assembly (IC50 0.812 μM). In mechanism studies, 16a was shown to block cell cycle in G2/M phase and to disrupt microtubule formation and displayed good antivascular properties as inhibition of cell migration, invasion, and endothelial tube formation. Compound 16a was evaluated in C57BL/6 mouse melanoma B16F10 xenograft model to validate its antitumor activity, in comparison with reference ABT-751 (1). Compound 16a displayed strong in vivo antitumor and antivascular activities at a dose of 5 mg/kg without obvious toxicity, whereas 1 needed a 10-fold higher concentration to reach similar effects.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000096926 Benzenesulfonamides A group of compounds that contain sulfonamide group S-linked to a benzene ring. Many benzenesulfonamide derivatives are pharmaceuticals (e.g., BOSENTAN; SULFAPYRIDINE; and SULFADIAZINE; CELECOXIB) as their sulfonamide moiety target various enzymes (e.g., CARBONIC ANHYDRASES; ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; and CYCLOOXYNENASE 2). Benzenesulfonamide,Benzenesulfonamide Derivatives,Benzenesulfonamide Monosodium Salt,Benzenesulphonamides,Benzosulfonamides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001581 Benzothiadiazines Heterocyclic compounds of a ring with SULFUR and two NITROGEN atoms fused to a BENZENE ring. Members inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin

Related Publications

Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
July 2015, Bioorganic & medicinal chemistry,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Synthesis and evaluation of substituted 3-(pyridin-2-yl)benzenesulfonamide derivatives as potent herbicidal agents.
February 2016, Bioorganic & medicinal chemistry,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents.
March 2019, Bioorganic chemistry,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Synthesis and biological evaluation of new disubstituted analogues of 6-methoxy-3-(3',4',5'-trimethoxybenzoyl)-1H-indole (BPR0L075), as potential antivascular agents.
August 2008, Bioorganic & medicinal chemistry,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues.
August 2022, Toxicology in vitro : an international journal published in association with BIBRA,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2',3',4'-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents.
March 1998, Journal of medicinal chemistry,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents.
April 2016, Bioorganic & medicinal chemistry letters,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and neuroprotective agents.
March 2015, Bioorganic & medicinal chemistry,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Design, synthesis, and biological evaluation of N-(pyridin-3-yl)pyrimidin-4-amine analogues as novel cyclin-dependent kinase 2 inhibitors for cancer therapy.
December 2023, Bioorganic chemistry,
Zacharie Segaoula, and Julien Leclercq, and Valérie Verones, and Nathalie Flouquet, and Marie Lecoeur, and Lionel Ach, and Nicolas Renault, and Amélie Barczyk, and Patricia Melnyk, and Pascal Berthelot, and Xavier Thuru, and Nicolas Lebegue
Design, synthesis and biological evaluation of novel homocamptothecin analogues as potent antitumor agents.
May 2015, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!